Synerkine Pharma
Company

Synerkine Pharma

Biotechnology Research Leiden, Zuid-holland, Nl 9 employees
Employees
9
Contacts
2
Emails
2

Synerkine Pharma Overview

Headquarters
Leiden, Zuid-holland, Nl
Industry
Biotechnology Research
Employees
9
Founded
2018
Funding
5.6M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Synerkine Pharma

Synerkine Pharma B.V. focuses on development of novel fusion proteins, called Synerkines, that combine the immunoregulatory activity of different cytokines. These fusion proteins have unique benefits over the individual cytokines and modulate a broad number of targets, including key elements in the pain pathway. This provides treatment options for chronic pain conditions with a clearly differentiated mechanism of action over current analgesic drugs and holds tremendous therapeutic and commercial potential. Synerkine Pharma B.V. was founded in 2018 as a spin-off of the University Medical Center Utrecht (UMCU), the Netherlands.

Synerkine Pharma Contact Details

People in AeroLeads
3
With contact data
2
Email contacts
2
66.7% coverage

Synerkine Pharma Org Chart

Sample employees and titles
Name Title Contact
Ted Fjällman Chief Executive Officer, Flerie
Email
Erik Manting CEO Mendus Ab (Publ)
Email
Jan Peter Van Suchtelen Jps Legal Bv
View

Employees by Management Level

Executive 2 profiles
Individual contributor 1 profile

Compare Similar Companies to Synerkine Pharma